Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

The Angels Initiative

Stroke prevention

  Drug Resistance

  Free Subscription

Articles published in PLoS Comput Biol

Retrieve available abstracts of 23 articles:
HTML format

Single Articles

    March 2022
  1. PENG Z, Maciel-Guerra A, Baker M, Zhang X, et al
    Whole-genome sequencing and gene sharing network analysis powered by machine learning identifies antibiotic resistance sharing between animals, humans and environment in livestock farming.
    PLoS Comput Biol. 2022;18:e1010018.
    PubMed     Abstract available

  2. GODIJK NG, Bootsma MCJ, van Werkhoven HC, Schweitzer VA, et al
    Does plasmid-based beta-lactam resistance increase E. coli infections: Modelling addition and replacement mechanisms.
    PLoS Comput Biol. 2022;18:e1009875.
    PubMed     Abstract available

    February 2022
  3. WANG S, Reeve SM, Holt GT, Ojewole AA, et al
    Chiral evasion and stereospecific antifolate resistance in Staphylococcus aureus.
    PLoS Comput Biol. 2022;18:e1009855.
    PubMed     Abstract available

    November 2021
  4. DUAN Q, Carmody C, Donovan B, Guy RJ, et al
    Modelling response strategies for controlling gonorrhoea outbreaks in men who have sex with men in Australia.
    PLoS Comput Biol. 2021;17:e1009385.
    PubMed     Abstract available

    October 2021
  5. JURASZ J, Baginski M, Czub J, Wieczor M, et al
    Molecular mechanism of proton-coupled ligand translocation by the bacterial efflux pump EmrE.
    PLoS Comput Biol. 2021;17:e1009454.
    PubMed     Abstract available

    September 2021
  6. POSADA-CESPEDES S, Van Zyl G, Montazeri H, Kuipers J, et al
    Comparing mutational pathways to lopinavir resistance in HIV-1 subtypes B versus C.
    PLoS Comput Biol. 2021;17:e1008363.
    PubMed     Abstract available

  7. KUOSMANEN T, Cairns J, Noble R, Beerenwinkel N, et al
    Drug-induced resistance evolution necessitates less aggressive treatment.
    PLoS Comput Biol. 2021;17:e1009418.
    PubMed     Abstract available

    August 2021
  8. BLASSEL L, Tostevin A, Villabona-Arenas CJ, Peeters M, et al
    Using machine learning and big data to explore the drug resistance landscape in HIV.
    PLoS Comput Biol. 2021;17:e1008873.
    PubMed     Abstract available

    June 2021
  9. ESENER N, Guerra AM, Giebel K, Lea D, et al
    Mass spectrometry and machine learning for the accurate diagnosis of benzylpenicillin and multidrug resistance of Staphylococcus aureus in bovine mastitis.
    PLoS Comput Biol. 2021;17:e1009108.
    PubMed     Abstract available

    March 2021
  10. ESPINOZA JL, Dupont CL, O'Rourke A, Beyhan S, et al
    Predicting antimicrobial mechanism-of-action from transcriptomes: A generalizable explainable artificial intelligence approach.
    PLoS Comput Biol. 2021;17:e1008857.
    PubMed     Abstract available

    January 2021
  11. KACHALOV VN, Nguyen H, Balakrishna S, Salazar-Vizcaya L, et al
    Identifying the drivers of multidrug-resistant Klebsiella pneumoniae at a European level.
    PLoS Comput Biol. 2021;17:e1008446.
    PubMed     Abstract available

  12. KAVCIC B, Tkacik G, Bollenbach T
    Minimal biophysical model of combined antibiotic action.
    PLoS Comput Biol. 2021;17:e1008529.
    PubMed     Abstract available

    December 2020
  13. LIBISELLER-EGGER J, Phelan J, Campino S, Mohareb F, et al
    Robust detection of point mutations involved in multidrug-resistant Mycobacterium tuberculosis in the presence of co-occurrent resistance markers.
    PLoS Comput Biol. 2020;16:e1008518.
    PubMed     Abstract available

    November 2020
  14. SAHA A, Dixit NM
    Pre-existing resistance in the latent reservoir can compromise VRC01 therapy during chronic HIV-1 infection.
    PLoS Comput Biol. 2020;16:e1008434.
    PubMed     Abstract available

    October 2020
  15. NGUYEN M, Olson R, Shukla M, VanOeffelen M, et al
    Predicting antimicrobial resistance using conserved genes.
    PLoS Comput Biol. 2020;16:e1008319.
    PubMed     Abstract available

    August 2020
  16. CLARELLI F, Palmer A, Singh B, Storflor M, et al
    Drug-target binding quantitatively predicts optimal antibiotic dose levels in quinolones.
    PLoS Comput Biol. 2020;16:e1008106.
    PubMed     Abstract available

  17. LANS I, Anoz-Carbonell E, Palacio-Rodriguez K, Ainsa JA, et al
    In silico discovery and biological validation of ligands of FAD synthase, a promising new antimicrobial target.
    PLoS Comput Biol. 2020;16:e1007898.
    PubMed     Abstract available

    July 2020
  18. PAGE AJ, Bastkowski S, Yasir M, Turner AK, et al
    AlbaTraDIS: Comparative analysis of large datasets from parallel transposon mutagenesis experiments.
    PLoS Comput Biol. 2020;16:e1007980.
    PubMed     Abstract available

  19. KRIEGER MS, Denison CE, Anderson TL, Nowak MA, et al
    Population structure across scales facilitates coexistence and spatial heterogeneity of antibiotic-resistant infections.
    PLoS Comput Biol. 2020;16:e1008010.
    PubMed     Abstract available

    May 2020
  20. CARBALLO-PACHECO M, Nicholson MD, Lilja EE, Allen RJ, et al
    Phenotypic delay in the evolution of bacterial antibiotic resistance: Mechanistic models and their implications.
    PLoS Comput Biol. 2020;16:e1007930.
    PubMed     Abstract available

    April 2020
  21. MARREC L, Bitbol AF
    Resist or perish: Fate of a microbial population subjected to a periodic presence of antimicrobial.
    PLoS Comput Biol. 2020;16:e1007798.
    PubMed     Abstract available

    March 2020
  22. HYUN JC, Kavvas ES, Monk JM, Palsson BO, et al
    Machine learning with random subspace ensembles identifies antimicrobial resistance determinants from pan-genomes of three pathogens.
    PLoS Comput Biol. 2020;16:e1007608.
    PubMed     Abstract available

    January 2020
  23. KIM J, Greenberg DE, Pifer R, Jiang S, et al
    VAMPr: VAriant Mapping and Prediction of antibiotic resistance via explainable features and machine learning.
    PLoS Comput Biol. 2020;16:e1007511.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Drug Resistance is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.